Liz Meszaros
Liz Meszaros is a freelance writer in eastern Pennsylvania.
Stargardt’s disease: New strategies, new therapies
Several therapies are in the pipeline to treat Stargardt’s disease.
Registries in glaucoma: Better science, better surveillance
Clinical registries can lead to better outcomes, better science, and better drug and device surveillance, reports William L. Rich, III, MD, FACS. Registry measures performance, both process measures in the office, and surgical interventions, and provides a forum to compare them and improve.
Is there a link between glaucoma and dementia?
For many years, researchers have suspected and tried to prove a link between glaucoma and dementia, said Yvonne Ou, MD. Definitive answers, however, have been hard to come by. Glaucoma and dementia have several factors in common: both are neurodegenerative, chronic, and progressive diseases that are age-related and cause irreversible neuronal cell loss. They are both becoming a major public health concern as the U.S. population ages.
Is there a link between HTN and glaucoma?
Ruth D. Williams, MD, a glaucoma consultant and partner at the Wheaton Eye Clinic, Naperville, IL, explored the possible effects and correlations in concomitant treatment of hypertension and glaucoma.
Big picture of glaucoma care presents with shades of gray
Glaucoma care in the United States has changed very little over the past 20 years. Kuldev Singh, MD, outlined the state of glaucoma in 2014. Only 25% to 50% of Americans with glaucoma are aware that they have glaucoma, and there are many more who are aware and not under regular care. Then, there are patients who are under regular care, but they may not be compliant with prescribed therapy. The bottom line is there is much room for improvement in the diagnosis and treatment of this glaucomatous disease.
Managing glaucoma means managing patient odds
Identifying and managing the risk factors of glaucoma is key to its effective management. Andrew G. Iwach, MD, says ophthalmologists are not treating means or averages,but individuals, and this requires a customized approach for every eye and every patient.
Poor performance and costs make healthcare reform necessary
Future healthcare reform is not a luxury. Rather, it is a necessity, especially when the performance and costs of healthcare in the United States are considered.
Ophthalmologists to see new payment models, increased patient access
Increased patients and patient access, new payment models, and the rise of comparative effectiveness research top the list of challenges that ophthalmologists will face in the future, according to William L. Rich, III, MD, FACS.
Providers navigate effects of 'Obamacare' with steps for increased efficiency
Negotiating the twists and turns that will be inherent to the Patient Protection and Affordable Care Act (PPACA)—commonly known as the Affordable Care Act (ACA) or “Obamacare”–could be tricky, said Terri Pickering, MD. In order to succeed, ophthalmologists must be aware of and ready for the inevitable changes.
How to transition to femtosecond laser-assisted cataract surgery
To prepare for the transition to femtosecond laser-assisted cataract surgery, surgeons must be prepared for the learning curve and other practical considerations this implementation requires.
var script= ' ';